July 12, 2017 10:31 AM EDT

Pfizer’s data mining hits pay dirt as FDA panel backs a comeback for Mylotarg

Seven years ago, Mylotarg was an embarrassment for Pfizer and the FDA. Regulators forced it off the market in 2010, right after Pfizer’s big Wyeth …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Pfiz­er’s da­ta min­ing hits pay dirt as FDA pan­el backs a come­back for My­lotarg